Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

641
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
641

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From blood draw to tumor infiltration: therapeutic variations in CAR-macrophage therapy for solid tumors.

Immunotherapy·2026
Same author

Establishment of Integrated Hospital-Based Supportive and Palliative Services: An Experience from Iran.

International journal of hematology-oncology and stem cell research·2026
Same author

Assessment of Anticancer Effect of Rhodium Nanoparticle-based Photodynamic Therapy via Protein-Protein Interaction Network Analysis.

Journal of lasers in medical sciences·2026
Same author

Evaluation of Synergic Effects of Molybdenum Disulfide Treatment and Near-Infrared Radiation on Human Mesenchymal Stem Cells.

Journal of lasers in medical sciences·2026
Same author

Human Gene Expression Profile Analysis of Insomnia and Pre-insomnia Disorders: A Cellular Study.

Basic and clinical neuroscience·2026
Same author

Introducing ICAM1 as a possible drug target in treatment of eosinophilic esophagitis.

Gastroenterology and hepatology from bed to bench·2026

Related Experiment Video

Updated: Aug 11, 2025

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
09:21

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons

Published on: July 7, 2023

1.6K

Stem Cell-Based Modeling Protocol for Parkinson's Disease.

Babak Arjmand1,2, Shayesteh Kokabi-Hamidpour3, Hamid Reza Aghayan3

  • 1Cell Therapy and Regenerative Medicine Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran. barjmand@sina.tums.ac.ir.

Methods in Molecular Biology (Clifton, N.J.)
|February 7, 2023
PubMed
Summary

Induced pluripotent stem cells offer a promising new approach for modeling Parkinson's disease. These patient-derived cells can differentiate into nerve cells, improving disease modeling and drug discovery.

Keywords:
Disease modelingEmbryoid bodyHuman-induced pluripotent stem cellsMidbrain dopaminergic neuronsParkinson’s diseaseStem cell-based models

More Related Videos

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies
12:13

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies

Published on: July 11, 2019

7.3K
Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test
08:06

Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test

Published on: January 15, 2010

31.7K

Related Experiment Videos

Last Updated: Aug 11, 2025

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
09:21

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons

Published on: July 7, 2023

1.6K
Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies
12:13

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies

Published on: July 11, 2019

7.3K
Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test
08:06

Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test

Published on: January 15, 2010

31.7K

Area of Science:

  • Neuroscience and Stem Cell Biology
  • Parkinson's Disease Pathogenesis

Background:

  • Parkinson's disease is a progressive neurodegenerative disorder impacting motor and non-motor functions.
  • Current treatments manage symptoms but do not offer a cure, partly due to limitations in disease models.
  • Dopaminergic system disturbances and synaptic dysfunction are key pathological features.

Purpose of the Study:

  • To highlight the potential of induced pluripotent stem cells (iPSCs) for modeling Parkinson's disease.
  • To address the limitations of existing laboratory models in Parkinson's research.
  • To introduce a novel approach for drug discovery and development pipelines.

Main Methods:

  • Utilizing cellular reprogramming of somatic cells to generate patient-specific induced pluripotent stem cells.
  • Leveraging the differentiation capacity of iPSCs into various cell types, including neurons.
  • Maintaining patient's genetic information within the iPSCs for accurate disease modeling.

Main Results:

  • Induced pluripotent stem cells provide a patient-specific platform for studying Parkinson's disease.
  • These cells can be differentiated into relevant neural cell types for in vitro studies.
  • The use of iPSCs enhances the quality and validity of Parkinson's disease models.

Conclusions:

  • Induced pluripotent stem cell technology represents a significant advancement in Parkinson's disease research.
  • This approach facilitates more accurate disease modeling and accelerates the development of potential therapeutics.
  • The chapter details the procedure for modeling Parkinson's disease using iPSCs.